Announced
Completed
Financials
Tags
Acquisition
United States
biotechnology company
Single Bidder
Biotechnology
Cross Border
Majority
Private
Friendly
Completed
Synopsis
Getinge, a global medical technology company, completed the acquisition of High Purity New England, a provider of single-use solutions for bioprocessing applications, for $290m. "This acquisition is another step in Getinge Life Science strategic journey to further expand our presence in the biopharma segment. High Purity New England has in recent years successfully supplied the industry with dedicated single use assemblies. We are delighted to join forces with HPNE providing our customers with comprehensive and innovative solutions for bioprocessing applications," Eric Honroth, Getinge President Life Science.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.